Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Cone Beam CT Scanning in Lung and Bladder Cancer.
Clinical trial update indicating the Cone Beam CT scanning study in lung and bladder cancer has completed. The update does not provide trial…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating concurrent chemotherapy with varying radiation dose intensity for limited-stage small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: DC Vaccine Combined With CIK Cells in Patients With SCLC [Phase 1, Phase 2]
The document describes an early-phase clinical trial testing a dendritic cell vaccine combined with cytokine-induced killer cells in patient…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer [Phase 2]
This document reports the completion of a Phase 2 trial evaluating hypofractionated radiotherapy for limited-stage small cell lung cancer.
-
CLINICAL_TRIALS research · 2016-02-10Clinical Trial Update: A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase Ib/II trial evaluating belotecan in combination with ifosfamide for extensive-disease small cell lung cancer; the study status is no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of temozolomide for relapsed sensitive or refractory small cell lung cancer has completed and results were posted in 2016.
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Temozolomide as Maintenance Therapy in Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating temozolomide as maintenance therapy in small cell lung cancer; the update provides no results in the snippet.
-
CLINICAL_TRIALS research · 2016-01-26Clinical Trial Update: Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) [Phase 3]
Phase 3 trial comparing Topotecan plus Cisplatin to Etoposide plus Carboplatin in first-line extensive-disease small cell lung cancer; the s…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 2]
A Phase 2 trial comparing linsitinib and topotecan hydrochloride in patients with relapsed small cell lung cancer. The study is completed an…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients [Phase 1, Phase 2]
A completed Phase 1/Phase 2 clinical trial update examining a gemcitabine-based regimen for small cell lung cancer in elderly patients.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pazopanib in patients with relapsed or refractory small cell lung cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer [Phase 2]
A Phase 2 safety and efficacy trial of a new chemotherapy agent for small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer [Phase 1]
A Phase I trial evaluating weekly topotecan in combination with sorafenib for relapsed small cell lung cancer has been completed. The study …
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the combination of amrubicin and carboplatin with pegfilgrastim in extensive-stage small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]
ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating cisplatin and etoposide with or without concurrent ZD6474 in previously untreated extensive-stage small ce…
-
FDA approval · 2015-11-17FDA Approved: TOPOTECAN HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's supplemental application for Topotecan hydrochloride, enabling a generic version of the cancer drug to be m…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating chemotherapy combined with radiation therapy for limited-stage small cell lung cancer has completed. The study wa…
-
CLINICAL_TRIALS withdrawal · 2015-11-13Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery [Phase 1]
Phase 1 trial of peripheral stem cell transplantation for metastatic or unresectable cancers including breast cancer, renal cell carcinoma, …
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy [Phase 2]
A Phase 2 study evaluating maintenance sorafenib in patients with small cell lung cancer after response to induction chemotherapy has been t…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Pazopanib in Relapsed and Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of pazopanib for relapsed and refractory small cell lung cancer has been completed.
-
CLINICAL_TRIALS withdrawal · 2015-10-07Clinical Trial Update: Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial of metronomic docetaxel and bevacizumab in small cell lung cancer has been withdrawn.
-
FDA approval · 2015-09-28FDA Approved: TOPOTECAN HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Topotecan Hydrochloride by Actavis Pharma, Inc., granting continued regulatory approval for this…
-
CLINICAL_TRIALS trial_result · 2015-09-09Clinical Trial Update: 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the combination of 7-hydroxystaurosporine and topotecan hydrochloride in relapsed or progressed small cell lung can…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage [Phase 2]
Phase II randomized trial comparing cisplatin/etoposide with either Hedgehog inhibitor GDC-0449 or IGF-1R monoclonal antibody IMC-A12 in ext…